Experiential Learning

Total Page:16

File Type:pdf, Size:1020Kb

Experiential Learning 18 | Monday, August 31, 2020 HONG KONG EDITION | CHINA DAILY LIFE Wang Guangfa (right), an expert from the National Health Commission, treats a COVID­19 patient at the Dalian Sixth People’s Hospital affiliated to Dalian Medical University in Liaoning province. PHOTOS PROVIDED TO CHINA DAILY Experiential learning Wang Guangfa’s battle with COVID­19 was different from that of other front­line experts, Li Yingxue reports. rom the SARS outbreak in their own feet. 2003 to the Wenchuan To be a respiratory physician, Earthquake in 2008, and Wang says that one needs to face from the H1N1 swine flu in many challenges, including a variety F2009 to the plague in the Inner Mon- of common illnesses, complicated golia autonomous region last year, pathogenic mechanisms and many Wang Guangfa, a respiratory expert difficult miscellaneous diseases. at Peking University First Hospital, During his 33 years of experience has spent his career on the front lines. in the field of pneumology, Wang has The COVID-19 pandemic was no been a pioneer of new technology in exception. He was in Wuhan, capital the treatment of patients. of Hubei province, as part of the “As the development of medical dis- National Health Commission’s ciplines bring more convenience to group of experts dispatched to the patients, doctors should continue to stricken city in early January. When learn,” Wang says. “It’s a huge risk to the pandemic reoccurred in the use new technology for the first time. coastal city of Dalian, Liaoning prov- But for the patients, we should have ince, in late July, Wang, 56, once the spirit to take up the challenge.” again packed up his gear and headed Wang says the use of new technolo- to the viral hot spot to help. Wang (center) in a meeting at the Dalian Sixth People’s Hospital Wang (second left) communicates with medical staff at the gy should not simply be to just to His fight against the epidemic was affiliated to Dalian Medical University in Liaoning. hospital. explore innovation, but should be slightly different this time — he was, based on the needs of the patient. for the first time, infected on the “When we are preparing an opera- front line. patients in the small space. I wore a transferred to hospital later that day. been applied in the ongoing preven- Wang now leads a team of 20, and tion, we are not only thinking about Confirmed positive for the novel N95 mask but no protective eye- His doctor recommended the use tion effort. has the further assistance of many how it could benefit the patient, but coronavirus on Jan 21, Wang spent wear,” Wang recalls. of HIV drugs, which combine lopina- One of his suggestions at the time experts from different fields, that use also what risks the patient might be nine days in hospital waging a per- The head of the fever clinic who vir with a low dose of ritonavir, which was to pay attention to patients in artificial intelligence to analyze the facing,” Wang says. sonal battle against the disease as a welcomed Wang also became infect- reduced Wang’s fever within a day. the cities around Wuhan. “Back cases of COVID-19 patients from Ma Jing, a colleague of Wang, says patient, and the experience also ed with COVID-19, showing symp- Wang recovered and was dis- then, all the focus was on the out- around the country. he has a strong will and a sense of helped him to better understand toms the very next day, which makes charged nine days after he was hos- break in Wuhan, but the city is the “We have collected data on more curiosity. COVID-19 and how to use that Wang more confident in his belief pitalized. capital of Hubei province and it was than 70,000 cases, including around She says Wang is always exploring knowledge to more effectively treat that he was infected at the Union The World Health Organization about time of Spring Festival with 15,000 cases that have full reports, new technologies, techniques and his patients. Hospital while he reviewing the subsequently stopped the trial of greater movement among the popu- which is a lot of work to do,” Wang ideas to help his patients, and he has infection process. lopinavir/ritonavir on hospitalized lation, so I noted that the cities says. an insight into the future trends of Solving the puzzle Wang returned to Beijing on Jan COVID-19 patients in July, because around Wuhan should also be con- As a former COVID-19 patient, his field. Wang arrived in Wuhan on Jan 8. 16 where he joined a meeting to offer the interim trial results showed that, cerned,” Wang says. Wang has gained more knowledge “The work is high-pressure, as the The following day, he visited Wuhan feedback on the Wuhan trip with the when compared the standard of care Wang also suggested speeding up and experience about the virus. As a patients who come to him from Jinyintan Hospital, checking the National Health Commission on the already being provided by hospitals, the detection process of the virus so doctor and a public health expert, across the country have a miscellany novel coronavirus patients in the same day. the drugs produced little or no that patients could be diagnosed as Wang says in light of the current of difficult illnesses, and some are ICU. Wang helped staff at the hospi- By the afternoon, he began feeling reduction in the mortality of those soon as possible. pandemic, doctors should shoulder even in a life-threatening position tal to intubate a patient. discomfort in his left eye, which soon infected. “I saw the doctors and nurses get- some responsibility concerning pub- when they arrive,” Ma says. Even though intubation is a proce- extended to his right. Both became “I was lucky that the drugs worked ting exhausted in Wuhan. They were lic health. Operating in the airways always dure that carries a risk of infection red. Wang developed a fever that on me, but it did have side effects, short-handed and under high pres- “The doctors in Wuhan have done carries a high risk, Ma notes, adding for the doctor, Wang believed that, night, with symptoms of nasal stuffi- like muscle weakness,” Wang says. sure,” Wang recalls. “I suggested a good job in identifying this new, that a patient might already be suf- with his protective clothing, N95 ness and a runny nose. beefing up the quota of medical staff infectious disease, but we still need fering from airway stenosis — a nar- mask, goggles and anti-spatter Wang thought he had caught the A new disease in Wuhan, as well as shortening to strengthen the awareness and vig- rowing trachea, commonly referred mask, the chance of him getting flu. He self-quarantined at home and On Jan 10, Wang told China Cen- their shifts. ilance among doctors,” Wang says. to as the windpipe — and the instru- infected was slim. treated himself with cold and flu tral Television that the outbreak was “The usual 8-hour shift was too ment required to enter the airway to On Jan 14, Wang visited the fever medicine but, four days later, the controllable, which caught the pub- long for them to be working in pro- Tech pioneer perform the operation occupies vital clinic at the Union Hospital affiliated fever had still not abated. lic’s attention. tective clothing, and if they were too Wang graduated from Beijing space. One mistake might cause to Tongji Medical College of Hua- “The 41 cases of COVID-19 He shared the fact that he had exhausted, their immunity might Medical University in 1987. He chose apnea. zhong University of Science and patients in Wuhan did not have become infected through the eyes on decrease and make them more vul- to become a respiratory physician According to Ma, if Wang is need- Technology. symptoms on the upper respiratory Sina Weibo, sending a warning to nerable to infection,” he says. after being deeply affected by his role ed by a patient when he is off duty, as In the small but crowded lobby, tract like me, which was why I both the public and medical workers After Wang was admitted into in helping to save the life of a serious- long as he is in Beijing, he will come Wang stayed for more than an hour thought I had flu at first,” Wang says. about the importance of eye protec- hospital, he received the files of 600 ly ill patient during his internship. to the hospital. “Even when you call talking to the patients. “Also, it was rare that I was infected tion. COVID-19 patients and was asked to He says among all professions, him at 2 am, he will come, and he “I was probably infected there through conjunctiva.” After the investigation in Wuhan, study them. After he was discharged, doctors are able to realize the value never complains.” through aerosol transmission, On Jan 21, Wang underwent a Wang presented his conclusions and he devoted himself to his work, shut- of their work when they help a because the room was not well venti- nucleic acid test and was confirmed suggestions to the National Health tling between his hospital and Nation- patient who enters the hospital on a Contact the writer at lated and there were too many to be infected with COVID-19. He was Commission, some of which have al Health Commission meetings. gurney, to recover and walk out on [email protected] Beijing film festival fosters overseas cooperation China has deepened its coopera- try’s filmmaking industrialization that resonates with global audien- tion with a number of countries in process,” Liu says.
Recommended publications
  • HRWF Human Rights in the World Newsletter Bulgaria Table Of
    Table of Contents • EU votes for diplomats to boycott China Winter Olympics over rights abuses • CCP: 100th Anniversary of the party who killed 50 million • The CCP at 100: What next for human rights in EU-China relations? • Missing Tibetan monk was sentenced, sent to prison, family says • China occupies sacred land in Bhutan, threatens India • 900,000 Uyghur children: the saddest victims of genocide • EU suspends efforts to ratify controversial investment deal with China • Sanctions expose EU-China split • Recalling 10 March 1959 and origins of the CCP colonization in Tibet • Tibet: Repression increases before Tibetan Uprising Day • Uyghur Group Defends Detainee Database After Xinjiang Officials Allege ‘Fake Archive’ • Will the EU-China investment agreement survive Parliament’s scrutiny? • Experts demand suspension of EU-China Investment Deal • Sweden is about to deport activist to China—Torture and prison be damned • EU-CHINA: Advocacy for the Uyghur issue • Who are the Uyghurs? Canadian scholars give profound insights • Huawei enables China’s grave human rights violations • It's 'Captive Nations Week' — here's why we should care • EU-China relations under the German presidency: is this “Europe’s moment”? • If EU wants rule of law in China, it must help 'dissident' lawyers • Happening in Europe, too • U.N. experts call call for decisive measures to protect fundamental freedoms in China • EU-China Summit: Europe can, and should hold China to account • China is the world’s greatest threat to religious freedom and other basic human rights
    [Show full text]
  • List of Participants
    WORLD HEALTH ORGANIZATION GLOBAL CONFERENCE ON SEVERE ACUTE RESPIRATORY SYNDROME (SARS) SARS: WHERE DO WE GO FROM HERE? SUNWAY LAGOON RESORT HOTEL, MALAYSIA, 17-18 JUNE 2003 LIST OF PARTICIPANTS Dr Preben AAVITSLAND National Institute of Public Health Section for infectious Diseases Control P.O. Box 4404 Nydalen 403 Oslo Norway Dr Zubaidah ABDUL WAHAB Clinical Microbiologist KICM Microbiology Unit Hospital Kuala Lumpur Kuala Lumpur Malaysia Dato' Dr Sulaiman ABDULLAH Ministry of Defense Health Service Division 50590 Kuala Lumpur Malaysia Dr Asmah Zainul ABIDIN Perak State Health Department Perak Malaysia Dr Camilo ACOSTA Seoul National University Campus Shillim-Dong Kwanak-Ku Republic of Korea WORLD HEALTH ORGANIZATION GLOBAL CONFERENCE ON SEVERE ACUTE RESPIRATORY SYNDROME (SARS) SARS: WHERE DO WE GO FROM HERE? SUNWAY LAGOON RESORT HOTEL, MALAYSIA, 17-18 JUNE 2003 Dr Tjandra ADITAMA Head Ministry of Health SARS Verification Team R.S. Persahabatan JL. Persehabatan 13230 Jakarta Indonesia Dr Ximena Paz AGUILLERA Head of Department of Epidemiology Ministerio de Salud MacIver 541 Santiago Chile Datin Dr Aziah AHMAT MAHYUDDIN Ministry of Health Malaysia 50590 Kuala Lumpur Malaysia Mazlomi Inurul AKMAR Ministry of Health (Protocol) 50590 Kuala Lumpur Malaysia Professor Dr Osman bin ALI Dean University Malaysia Sabah Faculty of Medicine Malaysia Dr Mohamed AL-JEFFRI Director General Prasitic and Infectious Diseases Ministry of Health, Riyadh Preventive Medicine Department General Directorate of Parasitic and Infectious Diseases 11176 Riyadh
    [Show full text]
  • Dokumentation Des COVID-19-Ausbruchs: Zeitleiste
    Dokumentation des COVID-19-Ausbruchs: Zeitleiste JOURNALISMUS MEIN BERICHT https://web.archive.org/web/20210611015902/https://www.jenniferzengblog.com/home/2021/6/1 0/documentary-of-covid-19-outbreak-timeline (Anmerkung von Jennifer: Dieses Dokument enthält hauptsächlich chinesische Nachrichtenberichte über COVID-19, die zu Beginn des Ausbruchs (vom 1. Dezember bis 31. Januar) veröffentlicht wurden. Einige davon wurden von chinesischen Nachrichtenmedien und lokalen chinesischen Regierungen veröffentlicht Hinweise auf die mögliche Absicht der chinesischen Regierung, die Epidemie zum Schweigen zu bringen und zu vertuschen. Viele Artikel wurden später aus dem Internet gelöscht, aber eine Gruppe von Interessierten hat sie auf GitHub gespeichert. Sie organisieren die Archive in einer Zeitleiste mit dem Zweck, "zu bewahren". Geschichte, damit die Wahrheit im Laufe der Zeit nicht verborgen oder vergessen wird. Die ursprüngliche Zeitleiste ist auf Chinesisch. Dies ist eine englische Übersetzung, damit westliche Leser auch die Wahrheit hinter dem Covid-19-Ausbruch erfahren können. Dies ist ein übersetztes Dokument. Das Originaldokument ist in (Chinesisch): https://web.archive.org/web/20200419085730/https://github.com/Pratitya /COVID-19-timeline/blob/master/TIMELINE.md 1. Dezember 2019 · Der erste Einwohner von Wuhan hatte Symptome einer ungeklärten Lungenentzündung (nach der Diagnose war es zu diesem Zeitpunkt eine unbekannte Lungenentzündung mit unbekannter Ursache und kein Arzt gefunden und gemeldet). Laut Wu Wenxuan, Direktor der Intensivstation (ICU) des Jinyintan Krankenhauses, war der Patient ein Mann in den 70ern mit einem leichten Hirninfarkt und Alzheimer. Nachdem er krank wurde, wurde er in ein anderes Krankenhaus in Wuhan eingeliefert, aber als sich sein Zustand verschlechterte, wurde er am 29. Dezember in das Jinyintan-Krankenhaus verlegt.
    [Show full text]
  • The COVID-19 Pandemic in Chiba Prefecture, Japan and Viet Nam: a Lesson- Learned in COVID-19 Pandemic Control in These Two Populations
    Asian Pacific Journal of Environment and Cancer Vol 3 No 1 (2020), 49-53 Articles The COVID-19 Pandemic in Chiba Prefecture, Japan and Viet Nam: A Lesson- learned in COVID-19 Pandemic Control in These Two Populations Furuuchi KANA School of Medicine, International University of Health and Welfare, Japan Yumi Ono School of Medicine, International University of Health and Welfare, Japan Limeng CHHEANG School of Medicine, International University of Health and Welfare, Japan Okada YUMA School of Medicine, International University of Health and Welfare, Japan Nagai YOUSUKE School of Medicine, International University of Health and Welfare, Japan Miu TAKEUCHI School of Medicine, International University of Health and Welfare, Japan Kuga HIROTOSHI School of Medicine, International University of Health and Welfare, Japan Le Hoa Duyen School of Medicine, International University of Health and Welfare, Japan Thaingi Hlaing School of Medicine, International University of Health and Welfare, Japan LE Tran Ngoan Dept. of Occupational Health, Hanoi Medical University, Hanoi, Viet Nam Aims: The study aimed to describe and compare the status of COVID-19 occurrence in Chiba prefecture and Viet Nam to recommend lesson-learned in COVID-19 control between two populations. Methods: We used the official database of COVID-19 published online by the Chiba Prefectural Government, and the Viet Nam Ministry of Health. The database’s variables include ID, age, gender, residence, sources of infection, the onset date of symptoms, and the positive confirmation date. The observation period starts on 23 January 2020, when the first positive patient appeared in Viet Nam and the end on 13 July 2020.
    [Show full text]
  • Comparing the Scope and Efficacy of COVID-19 Response Strategies In
    International Journal of Environmental Research and Public Health Article Comparing the Scope and Efficacy of COVID-19 Response Strategies in 16 Countries: An Overview Liudmila Rozanova 1,2,*, Alexander Temerev 1 and Antoine Flahault 1,2,3,4 1 Institute of Global Health, University of Geneva, 1202 Geneva, Switzerland; [email protected] (A.T.); antoine.fl[email protected] (A.F.) 2 Global Studies Institute, University of Geneva, 1205 Geneva, Switzerland 3 Swiss School of Public Health (SSPH+), 8001 Zurich, Switzerland 4 Hôpitaux Universitaires de Genève (HUG), 1205 Geneva, Switzerland * Correspondence: [email protected] Received: 17 October 2020; Accepted: 14 December 2020; Published: 16 December 2020 Abstract: This article synthesizes the results of case studies on the development of the coronavirus disease 2019 (COVID-19) pandemic and control measures by governments in 16 countries. When this work was conducted, only 6 months had passed since the pandemic began, and only 4 months since the first events were recognized outside of China. It was too early to draw firm conclusions about the effectiveness of measures in each of the selected countries; however, the authors present some efforts to identify and classify response and containment measures, country-by-country, for future comparison and analysis. There is a significant variety of policy tools and response measures employed in different countries, and while it is still hard to directly compare the different approaches based on their efficacy, it will definitely provide many inputs for the future data analysis efforts. Keywords: COVID-19; coronavirus; case studies; comparison; public health; epidemic response 1. Introduction In some European, North American, and South East Asian countries and territories, the first wave of the coronavirus disease 2019 (COVID-19) epidemic was showing a decline in late June 2020 when it was raging in other parts of the world, particularly in the United States, Latin America, South Africa, Saudi Arabia, Iran, India, Pakistan, Bangladesh, and Indonesia.
    [Show full text]
  • ASDSA) and American Society for Laser Medicine & Surgery (ASLMS) Guidance for Cosmetic Dermatology Practices During COVID-19
    American Society of Dermatologic Surgery Association (ASDSA) and American Society for Laser Medicine & Surgery (ASLMS) Guidance for Cosmetic Dermatology Practices During COVID-19 Based on information available as of 24 September 2020 Chairpersons: Murad Alam, MD, MBA & David M. Ozog, MD President of ASDSA: Marc D. Brown, MD President of ASLMS: Thomas E. Rohrer, MD _______________________________________________________________________________________ Authors: Shanthi Narla, MD Murad Alam, MD, MBA David M. Ozog, MD Vince Bertucci, MD, Henry Hin Lee Chan, MD, PhD, MRCP Mitchel P. Goldman, MD E. Victor Ross, MD David Sliney, PhD Marc D. Brown, MD Thomas E. Rohrer, MD 1 While dermatology practices have always followed optimal safety measures to protect and minimize infections for both patients, staff, and providers, the present COVID-19 environment with a variety of new (and changing) federal, state, and local health authority regulations encouraged the development of this document. Procedures should be performed in a manner that minimizes the risk of transmission of COVID-19. Evidence is sparse in certain areas regarding steps to reduce transmission risk. Even when limited evidence is available, it is not directly relevant to outpatient dermatology cosmetic procedures. Moreover, since individual cosmetic practices vary considerably, in terms of their typical patients, types of procedures performed, office physical plant, and other features, no detailed uniform guidance would be appropriate. In general, it is recommended that patients and healthcare providers wear at least surgical or homemade masks when possible. Additionally, routine handwashing by healthcare providers is recommended. Beyond these recommendations, the evidence for enhancing infection control beyond what has always been practiced is uncertain to absent, and no strong recommendations can be made.
    [Show full text]
  • Chinese Communist Party (CCP) Should Be Held to Account
    SPECIAL APRIL 2020 TRUTH AND TRADITION EGON999/SHUTTERSTOCK STR/AFP VIA GETTY IMAGES EXCLUSIVE CCP VIRUS COVERAGE How the Chinese Communist Party Giving the Right Name How China’s Coverup to the Virus Causing a Led to a Global Endangered Worldwide Pandemic Pandemic STORY ON 2 STORY ON 3 the World HECTOR RETAMAL/AFP VIA GETTY IMAGES The Chinese Communist Party’s coverup led to a pandemic that now threatens the lives of people around the globe. What really happened, and what lessons can we learn? READ MORE INSIDE Beijing’s ‘Mask 21 Million Fewer Cellphone Diplomacy’ Draws Users in China May Suggest Growing Backlash a High Death Toll STORY ON 4 STORY ON 6 Where Ties With Commu- Silenced: Stories of Citizens nist China Are Close, Suppressed for Speaking the the CCP Virus Follows Truth About the CCP Virus STORY ON 7 STORY ON 8 Senators Call for Reckoning With China’s Dictatorship MICHAEL MASTERS/GETTY IMAGES TRACEY NEARMY/GETTY IMAGES CADEN PEARSON Tasmanian Liberal Senator Eric Abetz said there needs to be a “reck- oning with the Chinese communist dictatorship and its leadership must be held to account” for its culpabil- ity in the spread of the CCP virus, commonly known as novel coro- navirus. “The decency of the Chinese peo- ple is not the issue. The Communist Senator Malcolm dictatorship’s decency under which Roberts in the the Chinese people suffer, however, Senate at Par- does need to be questioned,” he told liament House in The Epoch Times. Canberra on July Abetz listed a number of reasons 4, 2019.
    [Show full text]
  • Stand on the Same Side Against Covid-19 - Diagnostic, Screening Tools and Pathways For
    Firenze University Press www.fupress.com/substantia Webinar Stand on the Same Side Against Covid-19 - Diagnostic, Screening Tools and Pathways for Citation: L. Corbetta, S. Li, J. Li, G. M. Clinical and Preventive Purposes. Rossolini, L. M. Fabbri, W. Guangfa, Y. Qin Tai (2020) Stand on the Same Side Against Covid-19 - Diagnostic, Screening Tools and Pathways for Clinical and Preventive Purposes. This document is the direct transcription of a Webinar organized by Prof. L. Substantia 4(1) Suppl. 1: 967. Corbetta of the University of Florence on May 19th, 2020. DOI: 10.13128/Substantia-967 Received: Jun 08, 2020 Revised: Jun 16, 2020 Scientific coordination: Just Accepted Online: Jun 20, 2020 Lorenzo Corbetta Associate Professor of Respiratory Diseases - University of Florence Published: Jun 20, 2020 Scientific and Website Director of the European Association for Bronchology and Copyright: © 2020 L. Corbetta, S. Li, J. Interventional Pulmonology (EABIP) Li, G. M. Rossolini, L. M. Fabbri, W. Guangfa, Y. Qin Tai. This is an open Organizing Secretary: access, peer-reviewed article published Consorzio Futuro in Ricerca by Firenze University Press (http://www. fupress.com/substantia) and distributed Via Saragat 1 – Corpo B – 1° Piano | 44122 – Ferrara under the terms of the Creative [email protected] Commons Attribution License, which permits unrestricted use, distribution, Translation Coordination and Editing: and reproduction in any medium, Giorgia Biagini, MD provided the original author and source are credited. [email protected] Data Availability Statement: All rel- Webinar’s partecipants: evant data are within the paper and its Prof. Lorenzo Corbetta - University of Florence Supporting Information files.
    [Show full text]
  • Shailendra K. Saxena Editor Epidemiology, Pathogenesis
    Medical Virology: from Pathogenesis to Disease Control Series Editor: Shailendra K. Saxena Shailendra K. Saxena Editor Coronavirus Disease 2019 (COVID-19) Epidemiology, Pathogenesis, Diagnosis, and Therapeutics Medical Virology: from Pathogenesis to Disease Control Series Editor Shailendra K. Saxena Centre for Advanced Research, King George’s Medical University, Lucknow, India This book series reviews the recent advancement in the field of medical virology including molecular epidemiology, diagnostics and therapeutic strategies for various viral infections. The individual books in this series provide a comprehensive over- view of infectious diseases that are caused by emerging and re-emerging viruses including their mode of infections, immunopathology, diagnosis, treatment, epide- miology, and etiology. It also discusses the clinical recommendations in the man- agement of infectious diseases focusing on the current practices, recent advances in diagnostic approaches and therapeutic strategies. The books also discuss progress and challenges in the development of viral vaccines and discuss the application of viruses in the translational research and human healthcare. More information about this series at http://www.springer.com/series/16573 Shailendra K. Saxena Editor Coronavirus Disease 2019 (COVID-19) Epidemiology, Pathogenesis, Diagnosis, and Therapeutics Editor Shailendra K. Saxena Centre for Advanced Research King George’s Medical University Lucknow, India ISSN 2662-981X ISSN 2662-9828 (electronic) Medical Virology: from Pathogenesis to Disease Control ISBN 978-981-15-4813-0 ISBN 978-981-15-4814-7 (eBook) https://doi.org/10.1007/978-981-15-4814-7 © The Editor(s) (if applicable) and The Author(s), under exclusive licence to Springer Nature Singapore Pte Ltd. 2020 This work is subject to copyright.
    [Show full text]
  • Guidance for Cosmetic Dermatology Practices During COVID-19
    American Society of Dermatologic Surgery Association (ASDSA) and American Society for Laser Medicine & Surgery (ASLMS) Guidance for Cosmetic Dermatology Practices During COVID-19 Based on information available as of 11 January 2021 Chairpersons: Murad Alam, MD, MBA & David M. Ozog, MD Immediate Past President of ASDSA: Marc D. Brown, MD President of ASDSA: Mat Avram, MD President of ASLMS: Thomas E. Rohrer, MD _______________________________________________________________________________________ Authors: Shanthi Narla, MD Murad Alam, MD, MBA David M. Ozog, MD Vince Bertucci, MD, Henry Hin Lee Chan, MD, PhD, MRCP Mitchel P. Goldman, MD E. Victor Ross, MD David Sliney, PhD Marc D. Brown, MD Thomas E. Rohrer, MD 1 While dermatology practices have always followed optimal safety measures to protect and minimize infections for both patients, staff, and providers, the present COVID-19 environment with a variety of new (and changing) federal, state, and local health authority regulations encouraged the development of this document. Procedures should be performed in a manner that minimizes the risk of transmission of COVID-19. Evidence is sparse in certain areas regarding steps to reduce transmission risk. Even when limited evidence is available, it is not directly relevant to outpatient dermatology cosmetic procedures. Vaccines are now being distributed which will change the landscape of these recommendations over the next several months. Moreover, since individual cosmetic practices vary considerably, in terms of their typical patients, types of procedures performed, office physical plant, and other features, no detailed uniform guidance would be appropriate. In general, it is recommended that patients and healthcare providers wear at least surgical or homemade masks when possible.
    [Show full text]
  • COVID-19: Ocular Manifestations, Ocular Secretions, and Ocular Portal of Entry
    Advances in Ophthalmology & Visual System Mini Review Open Access COVID-19: ocular manifestations, ocular secretions, and ocular portal of entry Abstract Volume 10 Issue 2 - 2020 SARS-Cov-2 is a Coronovirus in the subfamily Coronavirinae, in the family Coronaviridae Brian M DeBroff and in the order of Nidovirales and is responsible for COVID-19 disease. General Professor of Clinical Ophthalmology and Visual Science, Yale characteristics of the virus are discussed with an emphasis on ocular manifestations of University School of Medicine, USA infection. In addition, the potential of ocular secretions including tears are reviewed as a potential for human to human spread of the virus. Finally, a discussion is made of the latest Correspondence: Brian M DeBroff, Professor of Clinical information on the eye as a portal for exposure and development of COVID-19 infection. Ophthalmology and Visual Science, Yale University School of Medicine, USA, 40 Temple Street, New Haven, CT 06510, Tel 203-785-2020, Email Received: April 14, 2020 | Published: April 27, 2020 Introduction described the findings of 38 patients with COVID-19 and severe pneumonia in Hubei Province, China. They found 31.6% of patients Nidovirales, derived from the Latin nidus (nest) is an order of single demonstrated ocular manifestations consistent with conjunctival stranded RNA genome viruses with both human and animal hosts hyperemia, chemosis, epiphora, or increased secretions.8 Only one and includes the family Coronaviridae, Roniviridae, Arteriviridae, patient presented with conjunctivitis as the first symptom.8 Of the 17 and Mesoniviridae. All viruses in this order produce a 3’ co-terminal patients recruited, none presented with ocular symptoms and only 1 nested set of subgenomic mRNA’s during infection.
    [Show full text]
  • Small Data, Big Time—A Retrospect of the First Weeks of COVID-19
    Small Data, Big Time—A retrospect of the first weeks of COVID-19 Qingyuan Zhao∗ [To be read before The Royal Statistical Society at the Society’s 2021 annual conference held in Manchester on Wednesday, September 8th, 2021, the President, Professor Sylvia Richardson, in the Chair] Abstract This article reviews some early investigations and research studies in the first weeks of the coron- avirus disease 2019 (COVID-19) pandemic from a statistician’s perspective. These investigations were based on very small datasets but were momentous in the initial global reactions to the pandemic. The article discusses the initial evidence of high infectiousness of COVID-19 and why that conclusion was not reached faster than in reality. Further reanalyses of some published COVID-19 studies show that the epidemic growth was dramatically underestimated by compartmental models, and the lack of fit could have been clearly identified by simple data visualization. Finally, some lessons for statisticians are discussed. Keywords: Infectious disease modeling; Selection bias; COVID-19; Model diagnostics. 1 Introduction Starting from a regional disease outbreak in Wuhan, China, the coronavirus disease 2019 (COVID-19) rapidly grew into a once-in-a-lifetime pandemic. As of the time of writing (December, 2020), the pandemic has already taken at least 1.5 million lives around the world. For anyone living through the COVID-19 pandemic, it is rubbing salt into their wounds to repeat more statistics about the disruptions of lives. Similar to many other new human diseases, there was an initial period of confusion. On December 31, 2019, the municipal Health Commission of Wuhan first reported a cluster of pneumonia cases of unknown etiology.
    [Show full text]